Metabolomics of colorectal cancer: Past and current analytical platforms

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 15, 2013, Pages 5013-5030

  Williams, Michael D ^a   Reeves, Raymond ^a   Resar, Linda S ^b   Hill Jr , Herbert H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioanalytical methods; Capillary electrophoresis electrophoresis; Gas chromatography; High performance liquid chromatography; Mass spectrometry inductively coupled plasma mass spectrometry; Nuclear magnetic resonance electron spin resonance

Indexed keywords

ANALYTICAL TECHNOLOGY; BIOANALYTICAL METHODS; COLORECTAL CANCERS (CRC); MASS SPECTROMETRY/INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES; METABOLIC PATHWAYS; METABOLIC PROFILES; PROTEIN SYNTHESIS; SPIN RESONANCE;

BIOMOLECULES; BIOSYNTHESIS; CAPILLARY ELECTROPHORESIS; DISEASES; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PATHOLOGY; TUMORS;

DIAGNOSIS;

CHEMICAL ANALYSIS; COLORECTAL TUMOR; EQUIPMENT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW;

CHEMISTRY TECHNIQUES, ANALYTICAL; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS;

EID: 84878280076     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6777-5     Document Type: Review

References (109)

1. Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519
2. Vander Heiden MG, Cantley LC, Thompson CB (2012) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029
3. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13:472
4. Hanahan D, Weinberg RA (2012) Hallmarks of cancer: the next generation. Cell 144:646
5. Van QN, Veenstra TD (2009) How close is the bench to the bedside? Metabolic profiling in cancer research. Genome Med 1:5
6. Claudino WM, Goncalves PH, di Leo A, Philip PA, Sarkar FH (2012) Metabolomics in cancer: a bench-to-bedside intersection. Crit Rev Oncol Hematol 84:1
7. Griffin JL (2004) Metabolic profiles to define the genome: can we hear the phenotypes? Philos Trans R Soc B Biol Sci 359:857
8. Fiehn O (2001) Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genom 2:155
9. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340
10. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325
11. Bayley J-P, Devilee P (2012) The Warburg effect in 2012. Curr Opin Oncol 24:62
12. Mentis A-FA, Kararizou E (2010) Metabolism and cancer: an up-to-date review of a mutual connection. Asian Pacific J Cancer Prev 11:1437
13. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18:598
14. ACS (2011) Colorectal cancer facts & figures 2011-2013. American Cancer Society, Atlanta, Georgia. http://www.cancer.org/research/ cancerfactsfigures/colorectalcancerfactsfigures/colorectal-cancer-facts-figures- 2011-2013-page
15. ACS (2012) Cancer facts & figures 2012. American Cancer Society, Atlanta, Georgia. http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf
16. Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8:4844
17. Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W (2012) Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 11:1354
18. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8:352
19. Dettmer K, Aronov PA, Hammock BD (2007) Mass spectrometry-based metabolomics. Mass Spectrom Rev 26:51
20. Dunn WB, Ellis DI (2005) Metabolomics: Current analytical platforms and methodologies. Trends Anal Chem 24:285
21. Dunn WB, Bailey NJC, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130
22. Bedair M, Sumner LW (2008) Current and emerging mass-spectrometry technologies for metabolomics. Trends Anal Chem 27:238
23. Theodoridis G, Gika HG, Wilson ID (2008) LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trends Anal Chem 27:251
24. Okada A, Takehara H, Yoshida K, Nishi M, Miyake H, Kita Y, Komi N (1993) Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med 40:19
25. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, Morishita Y (1999) Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 90:419
26. Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN (2010) Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics. doi: 10.1074/mcp.M900551-MCP200
27. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O (2008) Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover. Mol Cancer 7
28. Mal M, Koh PK, Cheah PY, Chan ECY (2009) Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun Mass Spectrom 23:487
29. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69:4918
30. Seierstad T, Røe K, Sitter B, Halgunset J, Flatmark K, Ree AH, Olsen D, Gribbestad IS, Bathen TF (2008) Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy. Mol Cancer 7
31. Piotto M, Moussallieh FM, Dillmann B, Imperiale A, Neuville A, Brigand C, Bellocq JP, Elbayed K, Namer IJ (2008) Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 5:292
32. Tessem M-B, Selnæs KM, Sjursen W, Tranø G, Giskeødegård GF, Bathen TF, Gribbestad IS, Hofsli E (2010) Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis. J Proteome Res 9:3664
33. Chae Y-K, Kang W-Y, Kim S-H, Joo J-E, Han J-K, Hong B-W (2010) Combining information of common metabolites reveals global differences between colorectal cancerous and normal tissues. Bull Korean Chem Soc 31:379
34. Ludwig C, Ward DG, Martin A, Viant MR, Ismail T, Johnson PJ, Wakelam MJO, Günther UL (2009) Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn Reson Chem 47:S68
35. Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhoffer M, Luchinat C, Nielsen DL, Turano P (2012) Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 72:356
36. Ritchie SA, Ahiahonu PWK, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB (2010) Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med 8
37. Lin CY, Wu H, Tjeerdema RS, Viant MR (2007) Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3:55
38. Wu H, Southam AD, Hines A, Viant MR (2008) High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal Biochem 372:204
39. Teahan O, Gamble S, Holmes E, Waxman J, Nicholson JK, Bevan C, Keun HC (2006) Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 78:4307
40. Want EJ, O'Maille G, Smith CA, Brandon TR, Uritboonthai W, Qin C, Trauger SA, Siuzdak G (2006) Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 78:743
41. Bruce SJ, Tavazzi I, Parisod V, Rezzi S, Kochhar S, Guy PA (2009) Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal Chem 81:3285
42. Boernsen KO, Gatzek S, Imbert G (2005) Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. Anal Chem 77:7255
43. Smith LM, Maher AD, Want EJ, Elliott P, Stamler J, Hawkes GE, Holmes E, Lindon JC, Nicholson JK (2009) Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. Anal Chem 81:4847
44. Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AFP (2003) A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33:1103
45. Kuhara T (2001) Diagnosis of inborn errors of metabolism using filter paper urine, urease treatment, isotope dilution and gas chromatography-mass spectrometry. J Chromatogr B: Biomed Sci Appl 758:3
46. Büscher M Jr, Czernik D, Ewald JC, Sauer U, Zamboni N (2009) Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal Chem 81:2135
47. Lindon JC, Nicholson JK, Holmes E, Keun HC, Craig A, Pearce JTM, Bruce SJ, Hardy N, Sansone S-A, Antti H, Jonsson P, Daykin C, Navarange M, Beger RD, Verheij ER, Amberg A, Baunsgaard D, Cantor GH, Lehman-McKeeman L, Earll M, Wold S, Johansson E, Haselden JN, Kramer K, Thomas C, Lindberg J, Schuppe-Koistinen I, Wilson ID, Reily MD, Robertson DG, Senn H, Krotzky A, Kochhar S, Powell J, van der Ouderaa F, Plumb R, Schaefer H, Spraul M (2005) Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol 23:833
48. Lu X, Zhao X, Bai C, Zhao C, Lu G, Xu G (2008) LC-MS-based metabonomics analysis. J Chromatogr B 866:64
49. Lindon JC, Nicholson JK (2008) Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 1:45
50. Lin L, Huang Z, Gao Y, Yan X, Xing J, Hang W (2011) LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. J Proteome Res 10:1396
51. Jordan KW, Nordenstam J, Lauwers GY, Rothenberger DA, Alavi K, Garwood M, Cheng LL (2009) Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum 52:520
52. Righi V, Durante C, Cocchi M, Calabrese C, Di Febo G, Lecce F, Pisi A, Tugnoli V, Mucci A, Schenetti L (2009) Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J Proteome Res 8:1859
53. Moreno A, Arús C (1996) Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed 9:33
54. Qiu Y, Cai G, Su M, Chen T, Liu Y, Xu Y, Ni Y, Zhao A, Cai S, Xu LX, Jia W (2010) Urinary metabonomic study on colorectal cancer. J Proteome Res 9:1627
55. Matz LM, Hill HH (2001) Evaluation of opiate separation by high-resolution electrospray ionization-ion mobility spectrometry/mass spectrometry. Anal Chem 73:1664
56. Dwivedi P, Schultz AJ Jr, Hill HH (2010) Metabolic profiling of human blood by high-resolution ion mobility mass spectrometry (IM-MS). Int J Mass Spectrom 298:78
57. Dwivedi P, Hill HH (2008) A rapid analytical method for hair analysis using ambient pressure ion mobility mass spectrometry with electrospray ionization (ESI-IMMS). Int J Ion Mobil Spectrom 11:61
58. Dwivedi P, Wu P, Klopsch SJ, Puzon GJ, Xun L, Hill HH (2008) Metabolic profiling by ion mobility mass spectrometry (IMMS). Metabolomics 4:63
59. Kaplan K, Dwivedi P, Davidson S, Yang Q, Tso P, Siems W, Hill HH (2009) Monitoring dynamic changes in lymph metabolome of fasting and fed rats by electrospray ionization-ion mobility mass spectrometry (ESI-IMMS). Anal Chem 81:7944
60. Kaplan K, Liu X, Fu Y-M, Lin H, Meadows GG, Siems W, Hill HH (2011) Metabolic differences among melanoma and two prostate cancer cell lines by electrospray ion mobility mass spectrometry. Int J Ion Mobil Spectrom 14:151
61. Lei Z, Huhman DV, Sumner LW (2011) Mass spectrometry strategies in metabolomics. J Biol Chem 286:25435
62. Wishart DS (2008) Quantitative metabolomics using NMR. Trends Anal Chem 27:228
63. Dzik-Jurasz ASK, Murphy PS, George M, Prock T, Collins DJ, Swift I, Leach MO, Rowland IJ (2002) Human rectal adenocarcinoma: demonstration of1H-MR spectra in vivo at 1.5 T. Magn Reson Med 47:809
64. Wang Y, Holmes E, Comelli EM, Fotopoulos G, Dorta G, Tang H, Rantalainen MJ, Lindon JC, Corthésy-Theulaz IE, Fay LB, Kochhar S, Nicholson JK (2007) Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. J Proteome Res 6:3944
65. Moreno A, Rey M, Montane JM, Alonso J, Arús C (1993) 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR Biomed 6:111
66. Merchant TE, Kasimos JN, de Graaf PW, Minsky BD, Gierke LW, Glonek T (1991) Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis 6:121
67. Merchant TE, Characiejus D, Kasimos JN, Den Otter W, Gierke LW, Glonek T (1992) Phosphodiesters in saponified extracts of human breast and colon tumors using 31P magnetic resonance spectroscopy. Magn Reson Med 26:132
68. Lean CL, Mackinnon WB, Mountford CE (1991) Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells. Magn Reson Med 20:306
69. Galons JP, Fantini J, Vion-Dury J, Cozzone PJ, Canioni P (1989) Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy. Biochimie 71:949
70. Kasimos JN, Merchant TE, Gierke LW, Glonek T (1990) 31P magnetic resonance spectroscopy of human colon cancer. Cancer Res 50:527
71. Elitsur Y, Moshier JA, Murthy R, Barbish A, Luk GD (1992) Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes. Life Sci 50:1417
72. Kingsnorth AN, Lumsden AB, Wallace HM (1984) Polyamines in colorectal cancer. Br J Surg 71:791
73. Idborg-Björkman H, Edlund P-O, Kvalheim OM, Schuppe-Koistinen I, Jacobsson SP (2003) Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Anal Chem 75:4784
74. Naidong W (2003) Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. J Chromatogr B 796:209
75. Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS (2005) High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 4:591
76. Nordström A, O'Maille G, Qin C, Siuzdak G (2006) Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal Chem 78:3289
77. Ramautar R, Demirci A, Jong GJD (2006) Capillary electrophoresis in metabolomics. Trends Anal Chem 25:455
78. Monton MRN, Soga T (2007) Metabolome analysis by capillary electrophoresis-mass spectrometry. J Chromatogr A 1168:237
79. Tang X, Bruce JE, Hill HH (2007) Design and performance of an atmospheric pressure ion mobility Fourier transform ion cyclotron resonance mass spectrometer. Rapid Commun Mass Spectrom 21:1115
80. Robinson EW, Williams ER (2005) Multidimensional separations of ubiquitin conformers in the gas phase: relating ion cross sections to H/D exchange measurements. J Am Soc Mass Spectrom 16:1427
81. Henderson SC, Valentine SJ, Counterman AE, Clemmer DE (1999) ESI/ion trap/ion mobility/time-of-flight mass spectrometry for rapid and sensitive analysis of biomolecular mixtures. Anal Chem 71:291
82. Woods AS, Ugarov M, Egan T, Koomen J, Gillig KJ, Fuhrer K, Gonin M, Schultz JA (2004) Lipid/peptide/nucleotide separation with MALDI-ion mobility-TOF MS. Anal Chem 76:2187
83. Woods AS, Ugarov M, Jackson SN, Egan T, Wang H-YJ, Murray KK, Schultz JA (2006) IR-MALDI-LDI combined with ion mobility orthogonal time-of-flight mass spectrometry. J Proteome Res 5:1484
84. Dwivedi P, Wu P, Klopsch S, Puzon G, Xun L, Hill H (2008) Metabolic profiling by ion mobility mass spectrometry (IMMS) 4:63
85. Clowers BH, Hill HH (2006) Influence of cation adduction on the separation characteristics of flavonoid diglycoside isomers using dual gate-ion mobility-quadrupole ion trap mass spectrometry. J Mass Spectrom 41:339
86. Tang K, Li F, Shvartsburg AA, Strittmatter EF, Smith RD (2005) Two-dimensional gas-phase separations coupled to mass spectrometry for analysis of complex mixtures. Anal Chem 77:6381
87. Ruotolo BT (2005) Evidence for macromolecular protein rings in the absence of bulk water. Science 310:1658
88. Merenbloom SI, Bohrer BC, Koeniger SL, Clemmer DE (2007) Assessing the peak capacity of IMS-IMS separations of tryptic peptide ions in He at 300 K. Anal Chem 79:515
89. Snyder AP, Thornton SN, Dworzanski JP, Meuzelaar HLC (1996) Detection of the picolinic acid biomarker in Bacillus spores using a potentially field-portable pyrolysis - gas chromatography - ion mobility spectrometry system. Field Anal Chem Technol 1:49
90. Valentine SJ, Kulchania M, Barnes CAS, Clemmer DE (2001) Multidimensional separations of complex peptide mixtures: a combined high-performance liquid chromatography/ion mobility/time-of-flight mass spectrometry approach. Int J Mass Spectrom 212:97
91. Muñoz-Pinedo C, El Mjiyad N, Ricci JE (2012) Cancer metabolism: current perspectives and future directions. Cell Death Dis 3
92. Giles K, Pringle SD, Worthington KR, Little D, Wildgoose JL, Bateman RH (2004) Applications of a travelling wave-based radio-frequency-only stacked ring ion guide. Rapid Commun Mass Spectrom 18:2401
93. Li H, Giles K, Bendiak B, Kaplan K, Siems WF, Hill HH (2012) Resolving structural isomers of monosaccharide methyl glycosides using drift tube and traveling wave ion mobility mass spectrometry. Anal Chem 84(7):3231-3239
94. Chong WPK, Goh LT, Reddy SG, Yusufi FNK, Lee DY, Wong NSC, Heng CK, Yap MGS, Ho YS (2009) Metabolomics profiling of extracellular metabolites in recombinant Chinese hamster ovary fed-batch culture. Rapid Commun Mass Spectrom 23:3763
95. García-Cañaveras JC, Donato MT, Castell JV, Lahoz A (2011) A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J Proteome Res 10:4825
96. Paglia G, Hrafnsdóttir S, Magnúsdóttir M, Fleming RMT, Thorlacius S, Palsson BØ, Thiele I (2011) Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). Anal Bioanal Chem 402:1183
97. Dong H, Zhang A, Sun H, Wang H, Lu X, Wang M, Ni B, Wang X (2012) Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol Biosyst 8
98. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277:63
99. Resar LMS (2010) The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res 70:436
100. Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL, Resar LMS (2012) HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS ONE 7
101. Berdinskikh NK, Ignatenko NA, Zaletok SP, Ganina KP, Chorniy VA (1991) Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. J Int Cancer 47:496
102. Phan SC, Morotomi M, Guillem JG, LoGerfo P, Weinstein IB (1991) Decreased levels of 1,2-sn-diacylglycerol in human colon tumors. Cancer Res 51:1571
103. Deberardinis RJ (2008) Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med 10:767
104. Turner MA, Simpson A, McInnes RR, Howell PL (1997) Human argininosuccinate lyase: a structural basis for intragenic complementation. Proc Natl Acad Sci USA 94:9063
105. Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B, Yan H (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA 108:3270
106. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739
107. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim S-H, Ito S, Yang C, Wang P, Xiao M-T (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17
108. Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, Seppanen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyotylainen T, Kallioniemi O, Iljin K, Oresic M (2011) Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71:3236
109. Brockmöller SF, Bucher E, Müller BM, Budczies J, Hilvo M, Griffin JL, Orešič M, Kallioniemi O, Iljin K, Loibl S, Darb-Esfahani S, Sinn BV, Klauschen F, Prinzler J, Bangemann N, Ismaeel F, Fiehn O, Dietel M, Denkert C (2012) Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer - link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res 11:850